pyrroles has been researched along with Atypical Mycobacterial Infection, Disseminated in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyce, CW; Bungard, CJ; Dartois, V; Dick, T; El Marrouni, A; Gengenbacher, M; Madani, A; Miller, RR; Murgolo, N; Negatu, DA; Olsen, DB; Zimmerman, MD | 1 |
| Alfonso, S; Battilocchio, C; Biava, M; Botta, M; Buroni, S; Canseco, JO; De Logu, A; De Rossi, E; Ioerger, TR; Javid, B; La Rosa, V; Manetti, F; Pasca, MR; Poce, G; Porretta, GC; Raju, RM; Rubin, EJ; Sacchettini, JC; Sorrentino, F | 1 |
2 other study(ies) available for pyrroles and Atypical Mycobacterial Infection, Disseminated
| Article | Year |
|---|---|
Activity of Tricyclic Pyrrolopyrimidine Gyrase B Inhibitor against Mycobacterium abscessus.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; DNA Gyrase; Mice; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pyrimidines; Pyrroles | 2022 |
MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212.
Topics: Animals; Antitubercular Agents; Carbon Radioisotopes; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cattle; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Genomic Library; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Mycobacterium bovis; Mycobacterium Infections, Nontuberculous; Mycobacterium smegmatis; Mycobacterium tuberculosis; Piperazines; Pyrroles; Reserpine; Verapamil | 2012 |